Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin prophylaxis for bone marrow transplant complications
IRCT201403281030N16Phase 3Completed
- Sponsor
- Hematology, Oncology and Stem Cell Transplantation Research Center
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of azithromycin in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML) and 1 more, sponsored by Hematology, Oncology and Stem Cell Transplantation Research Center. Started Aug 2013; status: completed.
02
Drugs
azithromycin
03
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)chronic myelogenous leukemia (CML)multiple myeloma (MM)
Beyond the preview
Go deeper on IRCT201403281030N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201403281030N16.